Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126905391 | 12690539 | 1 | I | 2016 | 20160624 | 20160826 | 20160826 | EXP | CN-ELI_LILLY_AND_COMPANY-CN201607000861 | ELI LILLY AND CO | 72.00 | YR | F | Y | 0.00000 | 20160824 | CN | DE | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126905391 | 12690539 | 1 | PS | CETUXIMAB | CETUXIMAB | 1 | Unknown | UNIT DOSE: 6 VIALS | 125084 | INJECTION | |||||||||
126905391 | 12690539 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | UNK | Y | 0 | ||||||||||
126905391 | 12690539 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | UNK | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126905391 | 12690539 | 1 | Colon cancer |
126905391 | 12690539 | 2 | Colon cancer |
126905391 | 12690539 | 3 | Colon cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126905391 | 12690539 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126905391 | 12690539 | Anal ulcer | |
126905391 | 12690539 | Nasal mucosal ulcer | |
126905391 | 12690539 | Off label use | |
126905391 | 12690539 | Paronychia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126905391 | 12690539 | 1 | 20160303 | 0 |